Results 91 to 100 of about 20,254 (207)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity

open access: yesNeuropsychiatric Disease and Treatment, 2022
Guangshuo Li,1 Chuanying Wang,1 Shang Wang,1,2 Yunyun Xiong,1– 3,* Xingquan Zhao1,2,* 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2China National Clinical Research Center ...
Li G, Wang C, Wang S, Xiong Y, Zhao X
doaj  

Imaging the ischaemic penumbra with T2* weighted MRI [PDF]

open access: yes, 2015
No abstract ...
McCabe, Christopher
core   +1 more source

Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase

open access: yesStroke: Vascular and Interventional Neurology
Background Nerinetide treatment was associated with better clinical outcomes among patients with stroke undergoing endovascular treatment who were not treated with concurrent alteplase in the randomized ESCAPE‐NA1 (Efficacy and Safety of Nerinetide for ...
Nathaniel B. Rex   +18 more
doaj   +1 more source

Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial

open access: yesAnnals of Intensive Care
Background Pulmonary intravascular thrombus formation has been widely observed in patients with respiratory failure, for example, in patients with SARS-CoV-2 infection (COVID-19).
Giovanni Landoni   +11 more
doaj   +1 more source

To Tube or Not to Tube? The Role of Intubation during Stroke Thrombectomy. [PDF]

open access: yes, 2014
In the 10 years since the FDA first cleared the use of endovascular devices for the treatment of acute stroke, definitive evidence that such therapy improves outcomes remains lacking.
Hinman, Jason D   +3 more
core   +2 more sources

Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases

open access: yesCase Reports in Neurological Medicine
Patients with acute branch atheromatous disease often experience early neurological deterioration (END) in the first 24-h period, even after intravenous alteplase. Three cases treated with cilostazol, a phosphodiesterase 3-inhibitor, prior to intravenous
Eijirou Tanaka   +4 more
doaj   +1 more source

Dual antiplatelet versus alteplase in anterior and posterior circulation minor stroke

open access: yesStroke and Vascular Neurology
Objective The Antiplatelet versus R-tPA for Acute Mild Ischaemic Stroke trial has demonstrated the non-inferiority of dual antiplatelet therapy (DAPT) to alteplase in minor non-disabling stroke.
Yu Cui, Hui-Sheng Chen
doaj   +1 more source

Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke [PDF]

open access: yes, 2017
BACKGROUND AND PURPOSE: Computed tomographic angiography and magnetic resonance angiography are used increasingly to assess arterial patency in patients with ischemic stroke.
,   +15 more
core   +2 more sources

Effect of concomitant usage of alteplase and mechanical thrombectomy for M1 middle cerebral artery occlusion on clinical outcome: a retrospective analysis of 457 patients from two centers

open access: yesFrontiers in Neurology
IntroductionEndovascular thrombectomy (EVT) and concomitant usage of intravenous alteplase (alteplase) in large vessel occlusion stroke may produce unwanted excess intracerebral hemorrhage (ICH). Whether this applies specifically to isolated occlusion of
Slaven Pikija   +10 more
doaj   +1 more source

Lingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase

open access: yesInternational Journal of General Medicine, 2012
Josef YayanDepartment of Internal Medicine, Vinzentius-Hospital, Landau, GermanyAbstract: Alteplase (recombinant tissue plasminogen activator) has been used in the treatment of acute ischemic stroke for 10 years.
Yayan J
doaj  

Home - About - Disclaimer - Privacy